Exploring the dual role of TP53 mutations in bladder cancer prognosis and treatment response, from basic biology to clinical implications.
Discover how cytotoxic T cells overcome BCR-ABL-mediated apoptosis resistance in chronic myeloid leukemia, revolutionizing cancer treatment through immunotherapy.
Discover how hybrid feature selection and EDA-based algorithms are revolutionizing peptide binding affinity prediction for vaccine and immunotherapy development.
Explore the revolutionary technologies enabling near real-time cancer detection and monitoring of immunotherapy failure within weeks of treatment initiation.
Discover how cutting-edge genomics is revealing the complex mechanisms of innate immunity and paving the way for precision immunotherapies.